Loading viewer...
investor_presentation
Format: PDF investor_presentation
Q4 Fiscal 2021 (Quarter Ended June 30, 2021) July 29, 2021
(Quarter Ended June 30, 2021)
July 29, 20212KLA N o n -Confid e n tia l | Un re s tricte dForward -Looking Statements
Statements in this presentation other than historical facts, such as statements pertaining to: (i ) growth rates for 2021; (ii) our ability to meet or
exceed our 2023 financial targets ahead of expectations; (iii) continued improvement of industry demand for semiconductors and WFE; (iv)
foundry/logic strength with our customers increasing their demand forecast in 2021; (v) the forecast of Optical Patterned Wafer Inspection to be
among the fastest- growing segments in WFE; (vi) our flagship reticle inspection business being on pace for a record year in 2021 ; (vii) continued
improvement of revenue throughout calendar year 2021; (viii) levels of business activity in the quarter ending September 30, 2021 and for
calendar 2021; (ix) future capital returns to shareholders; (x) our non- GAAP operating expenses for the quarter ending September 30, 2021 and
near term budget; (xi) our effective tax planning rate for the quarter ending September 30, 2021; (xii) WFE growth in 2021 and demand levels
across end markets; and (xiii) revenues, GAAP and non -GAAP gross margin and GAAP and non -GAAP diluted EPS for the quarter ending
September 30, 2021 and revenues across customer segments in the quarter ending September 30, 2021; are forward -looking statements and
subject to the Safe Harbor provisions created by the Private Securities Litigation Reform Act of 1995.
These forward -looking statements are based on current information and expectations and involve a number of risks and uncertainti es. Actual
results may differ materially from those projected in such statements due to various factors, including but not limited to: t he future impacts of
the COVID- 19 pandemic; delays and disruptions in the supply chain; the demand for semiconductors; the financial condition of the global capital
markets and the general macroeconomic environment; new and enhanced product and technology offerings by competitors; push -out of
deliveries or cancellation of orders by customers; the ability of KLA’s research and development teams to successfully innova te and develop
technologies and products that are responsive to customer demands; KLA’s ability to successfully manage its costs; market accept ance of KLA’s
existing and newly launched products; changing customer demands; and industry transitions. For other factors that may cause actual results to
differ materially from those projected and anticipated in forward- looking statements in this letter, please refer to KLA Corpora tion’s Annual
Report on Form 10 -K for the year ended June 30, 2021, and other subsequent filings with the Securities and Exchange Commission ( including,
but not limited to, the risk factors described therein). KLA Corporation assumes no obligation to, and does not currently int end to, update these
forward -looking statements.Strategic Overview and Highlights
Preview truncated — download the full document for the complete content.
29 Pages
KLA Corporation Investor Presentation — April 2022
investor_presentationinvestor_presentation
24 Pages
KLA Corporation Investor Presentation — April 2024
investor_presentationinvestor_presentation
18 Pages
investor_presentation
20 Pages
Better Choice Company
Pentamaster International 2024 Investor Presentation
investor_presentationinvestor_presentation
47 Pages
Pentamaster International Ltd.
Teva Pharmaceutical Industries Investor Presentation — October 2021
investor_presentationinvestor_presentation
39 Pages
Teva Pharmaceutical Industries